ArticleFrontiers in pharmacology2025

Ginsenoside Ro ameliorates cognitive impairment and neuroinflammation in APP/PS1 mice via the IBA1/GFAP-MAPK signaling pathway.

Tianyao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.